Type 2 Diabetes

The European Medicines Agency has announced it will evaluate all medications containing testosterone for cardiovascular risk.

The US Food and Drug Administration has approved Tanzeum (albiglutide), a once-weekly subcutaneous injection for the treatment of type 2 diabetes in adults.

A tool for diagnosing and monitoring diabetes has received 510(k) clearance from the US Food and Drug Administration.

The ACC/AHA cholesterol guideline can be a powerful tool for making multifactorial measures of cardiovascular disease risk assessment, particularly in African American populations, but clinicians should be aware of its limitations.

Clinicians should consider a patient's risk of hypoglycemia, the duration of time with the disease, age, comorbidities, vascular complications, and other factors when setting treatment goals.

Several studies have shown good results with Roux-en-Y gastric bypass and laparoscopic gastric banding when combined with lifestyle modifications in severely overweight patients with type 2 diabetes.

A 57-year-old man presented to clinic with this persistent skin lesion on his thumb. Three months ago, he lanced the lesion, producing some purulence and blood. Since then, it has bled almost daily and has not healed. He was treated with silver nitrate by another clinician after one month, but the lesion persists. His past medical history is significant for diabetes and his family history is significant for 2 cousins with melanoma.

It is worrisome that "high-impact" data read by most healthcare providers and then further interpreted and distributed by lay news organizations may have funder bias.

Study results show that more than one-third of men with diabetes have low serum testosterone levels, and that risk of low testosterone increases with age.

Diabetic retinopathy (DR) is currently the leading cause of blindness in working-age populations and among the most serious complications of chronic diabetes.

A study published in BMJ explains the long-term risks of opioid treatment in the postoperative setting.

Although the US Food and Drug Administration revised its approval processes for antihyperglycemic agents to include cardiovascular safety components, researchers still cannot discern whether those drugs affect cardiovascular outcomes.

Obesity rates – and associated patient suffering and societal costs – are climbing, despite the fact that biomedical and public health experts better understand the causes and have more tools to combat it.

A new retrospective study suggests that patients with autoimmune disorders should be monitored for epilepsy, and vice versa.

New research shows an oat-enriched diet plays a positive role in decreasing the inflammatory status involved in cardiovascular disease (CVD) associated with type 2 diabetes mellitus.

Medication adherence can be improved with increased patient knowledge, according to a study published in Diabetes Care.

Treatment with methylprednisolone was associated with increased risk of myocardial infarction in high-risk patients 30 days after bypass surgery.

Trial data presented at ACC.14 showed bariatric surgery was associated with much better long-term glycemic control in obese patients with diabetes compared with standard intensive medical therapy alone.

The reduction of the production of insulin has been attributed to kisspeptin 1, which has been noted as a key in the development of diabetes.

As more patients work in sedentary occupations, the health of the general population has declined. Some studies have revealed that sedentary workers rarely compensate for their inactivity by increasing their exercise levels and/or reducing their sedentary behavior during leisure time.

The AleCardio trial was halted early due to safety concerns and lack of efficacy. Investigators reported patients with diabetes and acute coronary syndrome experienced elevated risk of heart failure, gastrointestinal hemorrhage, and renal dysfunction with no mitigating cardiovascular benefit.

As they age, children who are diagnosed with diabetes shift from care supervised by parents or caregivers to self-care. Ultimately, they must leave their pediatric care providers and find internists and other caregivers whose practices target adults.

A developmental drug lowered low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia.

Patients with diabetes often develop thiamine deficiency secondary to elevated blood sugar. This deficiency is so common that some experts have referred to it as an epidemic.

Statins can cause diabetes, but other side effects are rare, according to a study published in the European Journal of Preventive Cardiology.

A once-weekly self-injection pen has been approved by the FDA to supplement diet and exercise for type 2 diabetes patients.

Early warning signs of atherosclerosis and other heart diseases may be evident in women who develop gestational diabetes, according to a study published in the Journal of the American Heart Association.

A study in the Journal of the American Dental Association suggests that periodontal disease and diabetes go hand in hand.

The US Food and Drug Administration (FDA) approved Myalept, a drug form of the hormone leptin, for the treatment of lipodystrophy.

One patient-centered medical home pilot was associated with improvement in only one of 11 quality areas and was not associated with reductions in hospital utilization or costs of care over 3 years.